COMPOSITIONS AND METHODS FOR USING PHORBOL ETHERS FOR TREATMENT OF STROKE Russian patent published in 2022 - IPC A61K36/47 A61K31/222 A61K31/225 A61K31/23 A61P25/28 

Abstract RU 2775972 C2

FIELD: pharmaceutical industry.

SUBSTANCE: group of inventions relates to the pharmaceutical industry, namely to a composition for the prevention or treatment of one or more consequences of a stroke in a mammal and a method for the prevention or treatment of one or more consequences of a stroke in a mammal. The composition for the prevention or treatment of one or more consequences of a stroke in a mammal includes the effective amount of phorbol ester of the formula I or its pharmaceutically acceptable salt, isomer or enantiomer,

where R1 and R2 are selected from a group consisting of hydrogen, hydroxyl, , where an alkyl group contains from 1 to 15 of carbon atoms; , where a lower alkenyl group contains from 1 to 7 carbon atoms; and ; and R3 is hydrogen and , where the specified phorbol ether of the formula I excludes 12-O-tetradecanoyl-phorbol-13-acetate (TPA), where one or more of side effects of a stroke is paralysis, spatial perception disorder, blurred consciousness, left ignoring syndrome, aphasia, problems with coordination and balancing, nausea, vomiting, cognitive disorder, perception disorder, orientation disorder, homonymous hemianopia, impaired mobility or impulsivity. The method for the prevention or treatment of one or more consequences of a stroke in a mammal includes the administration of the composition containing the effective amount of phorbol ether of the formula I or its pharmaceutically acceptable salt, isomer or enantiomer to the specified mammal.

EFFECT: above-described composition is effective for the prevention or treatment of one or more consequences of a stroke in a mammal, where one or more of side effects of a stroke is paralysis, spatial perception disorder, blurred consciousness, left ignoring syndrome, aphasia, problems with coordination and balancing, nausea, vomiting, cognitive disorder, perception disorder, orientation disorder, homonymous hemianopia, impaired mobility or impulsivity.

13 cl, 1 tbl, 10 ex

Similar patents RU2775972C2

Title Year Author Number
COMPOSITIONS AND METHODS OF USE OF PHORBOL ESTERS FOR THE TREATMENT OF STROKE 2013
  • Khan Chzhen Tao
  • Chen Khan-Fon
RU2650963C2
COMPOSITIONS AND METHODS OF USING PHORBOL ESTERS 2013
  • Khan Chzhen Tao
  • Chen Khan-Fon
RU2659684C2
COMPOSITIONS AND METHODS FOR APPLYING PHORBOL ESTERS 2008
  • Chan Richard L.
  • Khan' Chzhehn Tao
RU2472511C2
PHORBOL ESTER COMPOSITIONS AND METHODS OF USING THEM FOR TREATING OR REDUCING DURATION OF CYTOPENIA 2015
  • Han, Zheng Tao
RU2730998C2
PHARMACEUTICAL APPLICATIONS OF LANOST-8,24-DIEN-3-OLS 2008
  • Pjanovskij Luis Fransisku
  • Kalishtu Zhoao Batista
  • Leal Paulu Sezar
  • Shaves Klaudiu Paulinu
RU2476226C2
METHOD FOR ACHIEVING DESIRED GLIAL GROWTH FACTOR 2 PLASMA LEVELS 2014
  • Kim Khaesun
  • Kadzhano Entoni O.
RU2687097C2
METHOD OF PROVIDING REQUIRED LEVELS OF GLIAL GROWTH FACTOR 2 IN PLASMA 2009
  • Kim Khaesun
  • Kadzhano Ehntoni O.
RU2530650C2
COMBINATIONS FOR TREATING IMMUNO-INFLAMMATORY DISORDERS 2002
  • Kejt Kertis
  • Borajsi Aleksis
  • Tsimmermann Grant
  • Dzhost-Prajs Ehdvard Rojdon
  • Manivasakam Palanijandi
  • Kherst Nikol'
  • Fouli Majkl A.
RU2322984C2
METHODS AND COMPOSITIONS FOR TREATING INFLAMMATION AND ISCHEMIC DAMAGE 2012
  • Dokhil Randzhan
  • Fillips Syuzan A.
RU2638807C2
NOVEL ANTITUMOR COMPOUNDS 2003
  • Fehrklot Glinn Tomas
  • Ehlises Mar'Jano
  • Sasak Khalina
  • Aviles Marin Pablo Manuehl'
  • Kuehvas Marchante Marija Del' Karmen
RU2356908C2

RU 2 775 972 C2

Authors

Khan Chzhen Tao

Chen Khan-Fon

Dates

2022-07-12Published

2013-01-18Filed